Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes. - sprookjes - yvandenbroek - TriplyDB

Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes.

Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes.

http://www.wikidata.org/entity/Q34436139

about

Simultaneous Comparison of Efficacy and Tolerability of Second-Generation Antipsychotics in Schizophrenia: Mixed-Treatment Comparison Analysis Based on Head-to-Head Trial Data GetReal in network meta-analysis: a review of the methodology.Existing trial data do not support that hydroxyethyl starch is less harmful when given on more 'correct' indications.A multivariate model for the meta-analysis of study level survival data at multiple times A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making Network meta-analysis of longitudinal data using fractional polynomials.Treatment of idiopathic pulmonary fibrosis: a network meta-analysis.Efficacy of limited fluid resuscitation in patients with hemorrhagic shock: a meta-analysis Assumptions of Mixed Treatment Comparisons in Health Technology Assessments - Challenges and Possible Steps for Practical Application.Network Meta-analysis: Users' Guide for Surgeons: Part I - Credibility.Network Meta-analysis: Users' Guide for Surgeons: Part II - Certainty.Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis.Assessing key assumptions of network meta-analysis: a review of methods.Bayesian one-step IPD network meta-analysis of time-to-event data using Royston-Parmar models.Network meta-analysis including treatment by covariate interactions: Consistency can vary across covariate values.Multiple Score Comparison: a network meta-analysis approach to comparison and external validation of prognostic scores.Evaluation of biomarkers for treatment selection using individual participant data from multiple clinical trials.Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma.

P2860

Q28651174-6D821DEF-08D2-498D-A36B-FE04652D6F03 Q30251972-9D26DF7E-0E27-4E03-8932-AC1C96842DD9 Q30694964-13DF9A37-D5E2-464C-9170-F2A36E82A7FD Q30967736-51E61276-BE4C-4C92-A955-9761240A4E47 Q33830562-4EA79624-C39D-4355-BBBD-B49DE5A6D90C Q35034895-574C777C-AE84-4F2C-8D5C-23DC7EED83F5 Q35056525-7D0958AB-41E7-4D97-B151-B03B8775DBBE Q35602850-05473944-7E26-4323-95ED-F0D4BFF1F5AF Q35914125-C26DB90E-E3DB-4C20-AC8F-05B6F1BEC13D Q36046918-AFE65AA2-2B34-4063-A944-49514231BDF7 Q36100127-3A35DFBA-6D78-487F-8AAD-AB40AD25AE82 Q38418984-23CA15CE-4102-48B7-86EC-F9D65588D2E6 Q38418988-F3E96386-8270-4764-9B07-45832AD20A86 Q38436829-27CFF5AD-6C25-42EB-95DB-FF77E3597378 Q38520487-A0D1BFD5-9A28-4FC3-B840-C11447AF3DE0 Q38662083-763128C6-FC59-4B21-B471-BDB8131F8AFD Q38667868-E749CAF7-34DE-4130-BC88-5783CACF672C Q47161643-C41E5D03-1FF5-4C18-A74C-5E2F2C2FDFA5 Q49996939-3F25FAAE-CFD1-4909-B813-DE5B25E3090A Q53747880-6F97BD68-BE1A-4D58-A5D6-B5949236D161

P2860

Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes.

http://www.wikidata.org/entity/Q34436139

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Meta-regression models to addr ...... analysis of survival outcomes.

@ast

Meta-regression models to addr ...... analysis of survival outcomes.

@en

Meta-regression models to addr ...... analysis of survival outcomes.

@nl

type

label

Meta-regression models to addr ...... analysis of survival outcomes.

@ast

Meta-regression models to addr ...... analysis of survival outcomes.

@en

Meta-regression models to addr ...... analysis of survival outcomes.

@nl

prefLabel

Meta-regression models to addr ...... analysis of survival outcomes.

@ast

Meta-regression models to addr ...... analysis of survival outcomes.

@en

Meta-regression models to addr ...... analysis of survival outcomes.

@nl

P1433

Q34436139-1D8474AF-CE83-49F0-B53D-633A23029AF9

P1476

Q34436139-01B092F7-3763-4FF3-8CCD-618F2FA8510F

P2093

Q34436139-A06C63AB-8682-48BC-818E-28B4CAE450BD

Q34436139-EC4E4E7D-356D-4289-9021-DDBE69935789

P2860

Q34436139-03E9148B-3204-4822-AF09-8425B59A80DA

Q34436139-137C8DBA-2E00-455E-9C0C-39A5121011EB

Q34436139-2465F5AA-13A4-40C5-8CAE-D2E13B45F384

Q34436139-2EE9D8F0-6FDB-42B9-B1D6-D3A54D99DFFC

Q34436139-2EF48D49-16AE-4F7C-BB5A-AE35EF20B164

Q34436139-338CEEDC-E534-4146-903C-0EA0EFC1CDAF

Q34436139-43714962-A0CD-423E-B952-C6221245FB78

Q34436139-4F0BFF0B-0BEA-47AE-B341-8A3F4ADFEB64

Q34436139-60EACBC4-824C-43FE-A3F9-252387223DD7

Q34436139-6BA0208B-6B0D-48B3-9C56-A244BA69925A

P2888

Q34436139-F88454A9-1842-4D78-812D-944BB02A08A9

P304

Q34436139-473C770C-1B94-4A23-AFBB-92F177CD12D2

P31

Q34436139-709704F8-6C5F-4190-A7F9-6CF772367099

Q34436139-b2384092-857a-4977-8a91-0992cc129133

P356

Q34436139-CC6160DE-FB65-4F08-957C-874D383C2646

P478

Q34436139-6D4B75C1-E745-404F-8C04-70F53D409602

P577

Q34436139-CB900A62-2BFA-4E4B-8734-2A9CD091867A

P5875

Q34436139-253E1EDD-88A2-4D7D-8036-278602E37061

P6179

Q34436139-FF61A7B3-43FF-4A74-B92A-AE104F7C1125

P698

Q34436139-6CB704BB-875C-41F9-ABAD-5FC1CAA23093

P921

Q34436139-A32B861C-6105-4925-B4FC-27F5209AF9C3

P932

Q34436139-D3D24738-B66E-498B-9C0E-D430B6EDDA71

P356

1471-2288-12-152

P1433

BMC Medical Research Methodology

P1476

Meta-regression models to addr ...... analysis of survival outcomes.

@en

P2093

Jeroen P Jansen

http://www.w3.org/2001/XMLSchema#string

Shannon Cope

http://www.w3.org/2001/XMLSchema#string

P2860

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

Combination of direct and indirect evidence in mixed treatment comparisons

Network meta-analysis of individual and aggregate level data.

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients.

Network meta-analysis of survival data with fractional polynomials.

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.

Survival analysis for economic evaluations alongside clinical trials--extrapolation with patient-level data: inconsistencies, limitations, and a practical guide.

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Gr

P2888

1471-2288-12-152

P304

152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2288-12-152

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232221797

http://www.w3.org/2001/XMLSchema#string

P6179

1022104644

http://www.w3.org/2001/XMLSchema#string

P698

23043545

http://www.w3.org/2001/XMLSchema#string

P921

P932

3570315

http://www.w3.org/2001/XMLSchema#string